This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Orasure Technologies Inc., a for-profit manufacturer of medical diagnostic products. The contract is for the development and production of the OraQuick Zika Point-of-Care Test, with a ceiling value of $4,969,092.67. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an ultimate completion date of June 30, 2019. This contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Orasure Technologies Inc., also known as Orasure, is a global company that specializes in the development, manufacture, and marketing of oral fluid diagnostic products and specimen collection devices. Through this and other federal contract awards, Orasure has provided a wide range of medical diagnostic products, including rapid tests for diseases such as HIV, Ebola, Hepatitis C, and COVID-19, as well as alcohol detection tests, to various government agencies. Orasure holds two significant indefinite delivery vehicles (IDVs) for supplying medical diagnostic products to federal agencies, with a potential value of $107.28 million from the Defense Logistics Agency Troop Support Medical and $6.38 million from the GSA Federal Supply Schedule 65-VII.
Generated 4/1/25, 7:45 PM